Ozempic 1 mg Novo Nordisk
Additional information
| Active substance | Semaglutid |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low risk |
| Lab Test | Blood glucose levels, HbA1c |
| Also known as | N/A |
| Blood pressure | Can cause a reduction in blood pressure |
| Trade name | Ozempic, Rybelsus |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Chemical name | Semaglutide |
| Formula | C187H291N45O59 |
| Substance class | GLP-1 receptor agonist |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 1 week |
| Dosage (medical) | 0.25 mg once weekly, increasing to 0.5 mg and up to 1 mg as tolerated and needed |
| Dosage (sports) | Not recommended for use in sports |
| Effects | Improved glycemic control, weight loss |
| Side effects | Nausea, vomiting, diarrhea, abdominal pain, decreased appetite |
| Use in sports | None, not indicated for performance enhancement |
| Active ingredient, mg | 1 |
| Manufacturer | Novo Nordisk |
| Packing | Package (1 cartridge) |
| Release form | Cartridge |
Be the first to review “Ozempic 1 mg Novo Nordisk”
Related products
-
Sibra 15 mg Elbrus Pharmaceuticals
Select options This product has multiple variants. The options may be chosen on the product page -
Meltos (Clenbuterol) 40 mcg Pharmacom Labs
Select options This product has multiple variants. The options may be chosen on the product page -
Tanoliq Pen 15 mg SunSci Pharmaceutical
€75.00 Add to cart -
Clenbuterol 40 mkg Balkan Pharmaceuticals
Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.